Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hirsutism moderately affects the quality of life for most women, linked to condition severity.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Zinc helps reduce the severity of depression.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Finasteride helps reduce heart enlargement in heart failure patients.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.